Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CVS
CVS logo

CVS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
99.215
Open
99.160
VWAP
98.46
Vol
21.58M
Mkt Cap
125.45B
Low
97.840
Amount
2.13B
EV/EBITDA(TTM)
10.04
Total Shares
1.28B
EV
176.94B
EV/OCF(TTM)
17.13
P/S(TTM)
0.31
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
Show More

Events Timeline

(ET)
2026-06-17
07:30:00
Western Midstream Partners Launches Second Water Treatment Facility
select
2026-06-11 (ET)
2026-06-11
07:00:00
UnitedHealth and Others Deny 13% of Medical Requests
select
link
2026-05-28 (ET)
2026-05-28
08:20:00
ARCTRUST Acquires Seven Property Single-Tenant Portfolio
select
2026-05-28
07:40:00
Salesforce and CVS Health Expand Collaboration
select
2026-05-28
07:00:00
Eli Lilly Announces Coverage of Obesity Drugs by Three Major PBMs
select
2026-05-28
07:00:00
CVS Health Updates Commercial Formularies, Reintroduces Zepbound
select

News

Newsfilter
5.0
06-18Newsfilter
Pfizer CFO Dave Denton Resigns to Join Consumer Goods Sector
  • Executive Departure: Pfizer's CFO Dave Denton will resign on August 15 to pursue a role in the consumer goods sector, indicating increased executive turnover that may affect investor confidence.
  • Interim Appointment: Pfizer has appointed Cecile Guegan, senior vice president of finance for its global biopharmaceutical business, as interim CFO effective August 16, ensuring continuity in financial management and reducing uncertainty associated with executive transitions.
  • Past Achievements: Since joining Pfizer in 2022, Denton has been instrumental in major transactions, including the acquisitions of cancer therapy specialist Seagen, migraine drugmaker Biohaven, and obesity drug developer Metsera, enhancing the company's competitive position in the market.
  • Market Reaction: Following the announcement of Denton's resignation, Pfizer's shares fell 1.6% in premarket trading, reflecting market concerns over executive changes that could impact the company's future financial performance.
CNBC
6.5
06-18CNBC
Jim Cramer's Insights on Multiple Stocks
  • Fair Isaac Concerns: Despite growing worries about Fair Isaac's exposure to AI, analysts maintain a positive long-term outlook but choose to stay on the sidelines due to market uncertainties, reflecting caution regarding AI's impact on traditional business models.
  • Clover Health Investment Strategy: Analysts acknowledge their overly conservative view on Clover Health, recognizing its speculative potential while favoring long-term holdings in United Health and CVS, indicating a preference for more stable companies.
  • Vistra Price Volatility: Vistra's stock has experienced significant fluctuations, with analysts suggesting that the current price is too low and recommending a gradual build-up of positions, highlighting sensitivity to short-term market movements and expectations of a rebound.
  • Stryker Consolidation Expectations: Analysts express disappointment that Stryker's anticipated consolidation has not materialized, indicating a failure of the market to deliver expected consolidation opportunities and reflecting a sense of disillusionment with industry consolidation trends.
NASDAQ.COM
9.5
06-16NASDAQ.COM
CVS Health's Financial Performance Continues to Improve
  • Financial Recovery: CVS Health's revenue increased by approximately 6% year-over-year to $100.4 billion in Q1, with adjusted earnings per share rising 14% to $2.57, indicating a gradual recovery in profitability post-pandemic, which boosts investor confidence.
  • Declining Medical Benefit Ratio: The medical benefit ratio (MBR) dropped to 84.6%, down 2.7% from Q1 2025, suggesting improved efficiency in healthcare spending, which enhances overall profit margins and reflects effective cost management.
  • Successful Digital Transformation: By digitizing the prior authorization process, CVS Health has improved the efficiency of its insurance business, helping to control costs and increase profits, indicating that the company's strategic focus on technology investment is paying off.
  • Long-term Investment Appeal: CVS Health has increased its dividends by 56.5% over the past decade, with a forward dividend yield of 2.6%, and is trading at 13.8 times forward earnings, below the healthcare sector average of 17.4 times, highlighting its attractiveness for long-term investors.
Fool
9.5
06-16Fool
CVS Health Shows Strong Recovery Momentum
  • Financial Recovery: In Q1, CVS Health's revenue increased by approximately 6% year-over-year to $100.4 billion, with adjusted EPS rising 14% to $2.57, surpassing analyst expectations and indicating a gradual recovery in profitability post-pandemic.
  • Improved Medical Benefit Ratio: The medical benefit ratio (MBR) dropped to 84.6%, down 2.7% from Q1 2025, indicating enhanced efficiency in healthcare spending, which contributes positively to overall profit margins.
  • Digital Transformation Efforts: CVS Health has improved the efficiency of its insurance business by digitizing the prior authorization process, which not only helps control costs but also boosts the company's profitability, showcasing its competitive edge in the industry.
  • Long-Term Growth Potential: CVS Health's diversified healthcare model allows it to support patients throughout their care journey, and combined with its strong brand trust, it is well-positioned to benefit from global aging trends that will drive increased healthcare spending in the future.
Fool
2.0
06-15Fool
CVS Health Stock Surges on Medicare Developments
  • Stock Recovery: After a rough start to 2026, CVS Health shares have surged over 25% recently due to promising Medicare-related developments, indicating a strong market rebound that boosts investor confidence.
  • Analyst Target Increase: Mizuho analyst Ann Hynes raised CVS's price target from $110 to $115, presenting about a 13% upside from the current price of $100.68, reflecting optimistic market expectations for CVS's future performance.
  • Investor Sentiment Shift: As the stock price rises, investors are increasingly confident that CVS can continue to exceed expectations, moving beyond merely anticipating “better than expected” results, which could drive further price increases.
  • Valuation Potential: Currently trading at a forward P/E of 13.8, if CVS reaches $115 with projected earnings of $7.43 per share in 2026, the P/E would rise to 15.5, suggesting that a revaluation could push the stock price closer to $150.
NASDAQ.COM
6.0
06-15NASDAQ.COM
Mizuho Raises CVS Price Target to $115
  • Price Target Increase: Mizuho analyst Ann Hynes raised CVS Health's price target from $110 to $115, implying a potential upside of approximately 13%, reflecting market optimism regarding CVS's future performance.
  • Stock Recovery: After a rough start to 2026, CVS Health's shares have surged over 25%, indicating increased investor confidence in the company's promising developments related to Medicare, suggesting it may continue to exceed market expectations.
  • Valuation Potential: Currently trading at about 13.8 times forward earnings, if CVS's stock rises to $115, based on a forecasted earnings of $7.43 per share for 2026, it would imply a forward multiple of 15.5, showcasing CVS's competitive edge and growth potential in the healthcare sector.
  • Market Perception Shift: As CVS is recognized as a diversified healthcare services company, market understanding of its valuation is aligning more closely with that of UnitedHealth Group, and if CVS's forward multiple rises to as high as 20 times, its stock price could approach $150, further solidifying its status as a blue-chip stock.
Wall Street analysts forecast CVS stock price to rise
17 Analyst Rating
Wall Street analysts forecast CVS stock price to rise
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
Morgan Stanley
Overweight
maintain
$106 -> $111
AI Analysis
2026-06-04
Reason
Morgan Stanley
Price Target
$106 -> $111
AI Analysis
2026-06-04
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on CVS Health to $111 from $106 and keeps an Overweight rating on the shares. Managed care stocks have been "grinding higher" on emerging signs of softer utilization trends, notes the analyst, who also explores potential AI tailwinds for MCOs across revenue and cost levers that it says could deliver about 45% average EPS upside as efficiencies scale.
Truist
Buy
maintain
$102 -> $108
2026-06-01
Reason
Truist
Price Target
$102 -> $108
2026-06-01
maintain
Buy
Reason
Truist raised the firm's price target on CVS Health to $108 from $102 and keeps a Buy rating on the shares as part of a broader research note on Managed Healthcare names. The firm continues to see meaningful embedded earnings potential tied to ongoing margin recovery across the government businesses and also expects continued solid trends in Commercial business, the analyst tells investors in a research note. Q1 medical cost trends landed favorably to consensus expectations, with forward guidance maintaining an upward bias, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CVS
Unlock Now

Valuation Metrics

The current forward P/E ratio for CVS Health Corp (CVS.N) is 13.33, compared to its 5-year average forward P/E of 10.37. For a more detailed relative valuation and DCF analysis to assess CVS Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.37
Current PE
13.33
Overvalued PE
11.83
Undervalued PE
8.92

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.26
Current EV/EBITDA
10.40
Overvalued EV/EBITDA
14.73
Undervalued EV/EBITDA
5.80

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.29
Current PS
0.29
Overvalued PS
0.37
Undervalued PS
0.20

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what stock is pushing the market now
Intellectia · 111 candidates
Market Cap Category: largeRsi Category: moderateRelative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Week Price Change Pct: >= $0.00Month Price Change Pct: >= $0.00Is Index Component: GSPC, NDX, DJI
Ticker
Name
Market Cap$
top bottom
MRVL logo
MRVL
Marvell Technology Inc
173.97B
TMO logo
TMO
Thermo Fisher Scientific Inc
169.54B
GILD logo
GILD
Gilead Sciences, Inc
165.99B
GLW logo
GLW
Corning Inc
164.29B
HON logo
HON
Honeywell International Inc
146.72B
CRM logo
CRM
Salesforce Inc
145.21B
option with low spread for today
Intellectia · 192 candidates
Price: $20.00 - $500.00Market Cap Category: large, midRelative Vol: >= 1Is Optionable: TrueOption Iv Rank: 20 - 60Is Index Component: GSPC, NDX, DJI, RUT
Ticker
Name
Market Cap$
top bottom
NEE logo
NEE
Nextera Energy Inc
194.60B
DIS logo
DIS
Walt Disney Co
188.69B
BA logo
BA
Boeing Co
182.12B
ANET logo
ANET
Arista Networks Inc
178.49B
TMO logo
TMO
Thermo Fisher Scientific Inc
176.32B
T logo
T
AT&T Inc
175.52B
I need AI to pick a stock and manage it
Intellectia · 2 candidates
Sector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchIndustry: Food & Drug Retailing, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsVolume: >= -100Themes: Medical Instruments & Supplies, Pharmaceutical RetailersRsi Category: moderateMoving Average Relationship: PriceAboveMA5, PriceAboveMA20Monthly Average Dollar Volume: >= -100Macd: positive, bullish
Ticker
Name
Market Cap$
top bottom
CVS logo
CVS
CVS Health Corp
103.78B
EW logo
EW
Edwards Lifesciences Corp
47.44B
which stocks to buy short term
Intellectia · 40 candidates
Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $12.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
ELV logo
ELV
Elevance Health Inc
74.87B
QCOM logo
QCOM
Qualcomm Inc
158.82B
VTR logo
VTR
Ventas Inc
39.76B
KDP logo
KDP
Keurig Dr Pepper Inc
39.76B
PKG logo
PKG
Packaging Corp of America
18.95B
BKR logo
BKR
Baker Hughes Co
68.37B
today's stock picks
Intellectia · 74 candidates
Volume: >= 1,000,000Price Change Pct: $1.00 - $10.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Is Index Component: GSPC, NDX
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
329.83B
NUE logo
NUE
Nucor Corp
48.80B
MOH logo
MOH
Molina Healthcare Inc
9.17B
BEN logo
BEN
Franklin Resources Inc
14.12B
UDR logo
UDR
UDR Inc
11.42B
AVB logo
AVB
AvalonBay Communities Inc
23.98B
yes stocks
Intellectia · 27 candidates
Market Cap: >= 50.00BDividend Yield Ttm: 2.50 - 6Analyst Consensus: Strong Buy, Moderate BuyBeta: LowRiskRevenue 5yr Cagr: >= 7
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
618.95B
CVX logo
CVX
Chevron Corp
368.92B
KO logo
KO
Coca-Cola Co
329.83B
UNH logo
UNH
UnitedHealth Group Inc
322.34B
MRK logo
MRK
Merck & Co Inc
276.38B
PM logo
PM
Philip Morris International Inc
255.91B
stock of the day
Intellectia · 13 candidates
Market Cap: >= 5.00BPrice Change Pct: >= $3.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAR logo
CAR
Avis Budget Group Inc
6.73B
SSL logo
SSL
Sasol Ltd
7.96B
UNH logo
UNH
UnitedHealth Group Inc
255.38B
PSKY logo
PSKY
Paramount Skydance Corp
10.95B
HUM logo
HUM
Humana Inc
21.93B
AAOI logo
AAOI
Applied Optoelectronics Inc
8.35B
money market funds
Intellectia · 68 candidates
Market Cap: >= 1000.00MRegion: USBeta: LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEYear Price Change Pct: $2.00 - $8.00Monthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
321.48B
PM logo
PM
Philip Morris International Inc
252.94B
T logo
T
AT&T Inc
201.96B
CB logo
CB
Chubb Ltd
126.84B
SO logo
SO
Southern Co
106.81B
DUK logo
DUK
Duke Energy Corp
100.69B
best stocks to short
Intellectia · 70 candidates
Market Cap: >= 1000.00MPe Ttm: >= 40List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Annual Eps Yoy Growth: <= -10.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TSLA logo
TSLA
Tesla Inc
1.38T
SHOP logo
SHOP
Shopify Inc
152.29B
PANW logo
PANW
Palo Alto Networks Inc
132.97B
COF logo
COF
Capital One Financial Corp
112.86B
CEG logo
CEG
Constellation Energy Corp
102.16B
CVS logo
CVS
CVS Health Corp
90.94B
which has the highest return?
Intellectia · 14 candidates
Market Cap: >= 5.00BRegion: USPrice: $10.00 - $150.00One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 3,000,000
Ticker
Name
Market Cap$
top bottom
LNC logo
LNC
Lincoln National Corp
6.85B
CVS logo
CVS
CVS Health Corp
96.93B
RRR logo
RRR
Red Rock Resorts Inc
6.46B
PINS logo
PINS
Pinterest Inc
11.69B
MFC logo
MFC
Manulife Financial Corp
59.36B
QGEN logo
QGEN
Qiagen NV
10.06B

Whales Holding CVS

M
Maple Rock Capital Partners Inc.
Holding
CVS
+49.96%
3M Return
S
SRS Investment Management, LLC
Holding
CVS
+28.43%
3M Return
C
Cacti Asset Management, LLC
Holding
CVS
+27.12%
3M Return
E
Epoch Investment Partners, Inc.
Holding
CVS
+26.17%
3M Return
D
Deroy & Devereaux Private Investment Counsel, Inc.
Holding
CVS
+24.12%
3M Return
A
Argenta Asset Management SA
Holding
CVS
+20.89%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is CVS Health Corp (CVS) stock price today?

The current price of CVS is 98.32 USD — it has decreased -0.85

What is CVS Health Corp (CVS)'s business?

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

What is the price predicton of CVS Stock?

Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is96.71 USD with a low forecast of 91.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CVS Health Corp (CVS)'s revenue for the last quarter?

CVS Health Corp revenue for the last quarter amounts to 100.43B USD, increased 6.17

What is CVS Health Corp (CVS)'s earnings per share (EPS) for the last quarter?

CVS Health Corp. EPS for the last quarter amounts to 2.30 USD, increased 63.12

How many employees does CVS Health Corp (CVS). have?

CVS Health Corp (CVS) has 300000 emplpoyees as of June 21 2026.

What is CVS Health Corp (CVS) market cap?

Today CVS has the market capitalization of 125.45B USD.